341. Spontaneously reported haemorrhagic adverse events associated with rivaroxaban and dabigatran in Australia. (February 2016) Authors: Chen, Esa Y. H.; Diug, Basia; Bell, J. Simon; Mc Namara, Kevin P.; Dooley, Michael J.; Kirkpatrick, Carl M.; McNeil, John J.; Caughey, Gillian E.; Ilomäki, Jenni Journal: Therapeutic advances in drug safety Issue: Volume 7:Number 1(2016:Feb.) Page Start: 4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
342. Stimulant pharmacotherapy for adults with attention deficit hyperactivity disorder: cardiovascular effects and risk of sudden cardiac death. (August 2016) Authors: Pucci, Mark Journal: Adverse drug reaction bulletin Issue: Volume 299:Number 1(2016) Page Start: 1155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
343. Strategies to promote public engagement around deprescribing. (November 2018) Authors: Turner, Justin P.; Currie, Janet; Trimble, Johanna; Tannenbaum, Cara Journal: Therapeutic advances in drug safety Issue: Volume 9:Number 11(2018) Page Start: 653 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
344. Structured benefit–risk evaluation for medicinal products: review of quantitative benefit–risk assessment findings in the literature. (December 2020) Authors: Kürzinger, Marie-Laure; Douarin, Ludivine; Uzun, Ievgeniia; El-Haddad, Chantal; Hurst, William; Juhaeri, Juhaeri; Tcherny-Lessenot, Stéphanie Journal: Therapeutic advances in drug safety Issue: Volume 11(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
345. SUBJECT AND DRUG INDEXES TO ADVERSE DRUG REACTION BULLETIN: Nos 320–325 February 2020 – December 2020. (December 2020) Authors: N/A, Journal: Adverse drug reaction bulletin Issue: Volume 325:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
346. SUBJECT AND DRUG INDEXES TO ADVERSE DRUG REACTION BULLETIN: Nos 326–331 February 2021 – December 2021. (December 2021) Authors: N/A, Journal: Adverse drug reaction bulletin Issue: Volume 331:Number 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
347. Subject and Drug Indexes to Adverse Drug Reaction Bulletin: Nos 332–337 February 2022 – December 2022. (December 2022) Journal: Adverse drug reaction bulletin Issue: Volume 337:Number 1(2022) Page Start: 00 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
348. Subject Index 2017. (December 2017) Authors: N/A, Journal: Adverse drug reaction bulletin Issue: Volume 307:Number 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
349. Subject Index. (December 2016) Authors: N/A, Journal: Adverse drug reaction bulletin Issue: Volume 301:Number 1(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
350. Subject Index. (December 2016) Journal: Adverse drug reaction bulletin Issue: Volume 301:Number 1(2016) Page Start: 1168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗